{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:43:42Z","timestamp":1789778622556,"version":"4.0.1"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vasopressin is a non-adrenergic vasopressor, commonly used in distributive shock, that may offer therapeutic benefits in selected phenotypes of cardiogenic shock.<\/jats:p>\n                  <jats:p>This review presents a comprehensive synthesis of its pharmacologic mechanisms, haemodynamic effects, clinical applications, and potential adverse outcomes in this complex setting. We delineate clinical scenarios in which vasopressin may be advantageous, critically appraise the current evidence, and support a physiology-guided, individualized approach to treatment.<\/jats:p>\n                  <jats:p>Patient profiles that may particularly benefit include advanced or mixed cardiogenic shock with low systemic vascular resistance, tachyarrhythmia-related shock, post-cardiac arrest shock, acute right ventricular failure, mitral stenosis, prosthetic mitral valve thrombosis, dynamic left ventricular outflow tract obstruction, Takotsubo syndrome, and severe aortic stenosis. In these settings, vasopressin\u2019s non-adrenergic mechanism of action may improve perfusion pressure while mitigating catecholamine-related adverse effects.<\/jats:p>\n                  <jats:p>We also outline clinical scenarios of cardiogenic shock in which vasopressin use may be detrimental and discuss its implications in patients receiving mechanical circulatory support.<\/jats:p>\n                  <jats:p>Finally, we highlight the need for prospective studies to optimize vasopressor selection in this high-risk and heterogeneous population.<\/jats:p>","DOI":"10.1093\/eschf\/xvag053","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:51:44Z","timestamp":1770900704000},"source":"Crossref","is-referenced-by-count":3,"title":["Vasopressin in cardiogenic shock: pathophysiology, clinical evidence, and therapeutic perspectives"],"prefix":"10.1093","volume":"13","author":[{"given":"Simone","family":"Filomia","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Giuseppe","family":"Del Buono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Saponara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"d\u2019Aiello","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pedicino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Moroni","sequence":"additional","affiliation":[{"name":"Berne Cardiovascular Research Center, University of Virginia , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[{"name":"Berne Cardiovascular Research Center, University of Virginia , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5760-6885","authenticated-orcid":false,"given":"Tommaso","family":"Sanna","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , L.go A. Gemelli, Rome 1\u201300168 ,","place":["Italy"]},{"name":"Department of Cardiovascular and Respiratory Sciences, Catholic University of the Sacred Heart , Largo Francesco Vito, 1, Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"2026050202262561300_xvag053-B1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/FJC.0000000000001584","article-title":"Clinical characteristics, management, and outcomes in cardiogenic shock: insights from a high-volume Italian cardiac intensive care unit","volume":"84","author":"Del Buono","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026050202262561300_xvag053-B2","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","article-title":"Cardiogenic shock","volume":"404","author":"L\u00fcsebrink","year":"2024","journal-title":"Lancet"},{"key":"2026050202262561300_xvag053-B3","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026050202262561300_xvag053-B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bpa.2008.03.003","article-title":"Physiology of the vasopressin receptors","volume":"22","author":"Maybauer","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2026050202262561300_xvag053-B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40981-016-0072-3","article-title":"Effect of arginine vasopressin on systemic and pulmonary arterial pressure in a patient with pulmonary hypertension secondary to pulmonary emphysema: a case report","volume":"3","author":"Mizota","year":"2017","journal-title":"JA Clin Rep"},{"key":"2026050202262561300_xvag053-B6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/01.ccm.0000810708.23191.69","article-title":"Effect of norepinephrine versus vasopressin on pulmonary artery pressure","volume":"50","author":"Korkames","year":"2022","journal-title":"Crit Care Med"},{"key":"2026050202262561300_xvag053-B7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1378\/chest.103.4.1241","article-title":"Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery: V1-receptor-mediated production of nitric oxide","volume":"103","author":"Evora","year":"1993","journal-title":"Chest"},{"key":"2026050202262561300_xvag053-B8","doi-asserted-by":"publisher","first-page":"H1228","DOI":"10.1152\/ajpheart.1989.257.4.H1228","article-title":"Effects of vasopressin on pulmonary and systemic vascular mechanics","volume":"257","author":"Wallace","year":"1989","journal-title":"Am J Physiol"},{"key":"2026050202262561300_xvag053-B9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.ejcts.2006.02.032","article-title":"Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients","volume":"29","author":"Jeon","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026050202262561300_xvag053-B10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1177\/08850666221081836","article-title":"Influence of timing and catecholamine requirements on vasopressin responsiveness in critically ill patients with septic shock","volume":"37","author":"Jakowenko","year":"2022","journal-title":"J Intensive Care Med"},{"key":"2026050202262561300_xvag053-B11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"2026050202262561300_xvag053-B12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00134-019-05551-y","article-title":"Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality","volume":"45","author":"Meyfroidt","year":"2019","journal-title":"Intensive Care Med"},{"key":"2026050202262561300_xvag053-B13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"2026050202262561300_xvag053-B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13054-023-04574-8","article-title":"Real life use of vasopressin in patients with cardiogenic shock: a retrospective cohort analysis","volume":"27","author":"Nguyen","year":"2023","journal-title":"Crit Care"},{"key":"2026050202262561300_xvag053-B15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.amjcard.2005.07.078","article-title":"Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction","volume":"96","author":"Jolly","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026050202262561300_xvag053-B16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/cc7954","article-title":"Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?","volume":"13","author":"Asfar","year":"2009","journal-title":"Crit Care"},{"key":"2026050202262561300_xvag053-B18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"2026050202262561300_xvag053-B19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1345\/aph.1H498","article-title":"Thromboembolic events during continuous vasopressin infusions: a retrospective evaluation","volume":"41","author":"Doepker","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2026050202262561300_xvag053-B20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamasurg.2019.2884","article-title":"Effect of low-dose supplementation of arginine vasopressin on need for blood product transfusions in patients with trauma and hemorrhagic shock: a randomized clinical trial","volume":"154","author":"Sims","year":"2019","journal-title":"JAMA Surg"},{"key":"2026050202262561300_xvag053-B21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.cir.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/eurheartj\/ehs487","article-title":"Circulating angiopoietins and cardiovascular mortality in cardiogenic shock","volume":"34","author":"Link","year":"2013","journal-title":"Eur Heart J"},{"key":"2026050202262561300_xvag053-B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13613-016-0229-2","article-title":"Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock","volume":"7","author":"Tolppanen","year":"2017","journal-title":"Ann Intensive Care"},{"key":"2026050202262561300_xvag053-B24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13613-024-01388-x","article-title":"Biomarkers in cardiogenic shock: old pals, new friends","volume":"14","author":"Jozwiak","year":"2024","journal-title":"Ann Intensive Care"},{"key":"2026050202262561300_xvag053-B25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/CCM.0b013e3181957532","article-title":"The vasopressin and copeptin response to infection, severe sepsis, and septic shock","volume":"37","author":"Jochberger","year":"2009","journal-title":"Crit Care Med"},{"key":"2026050202262561300_xvag053-B26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","article-title":"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)","volume":"22","author":"Jeon","year":"2018","journal-title":"Crit Care"},{"key":"2026050202262561300_xvag053-B27","doi-asserted-by":"publisher","first-page":"P383","DOI":"10.1186\/cc7547","article-title":"Copeptin is a strong and independent predictor of outcome in cardiogenic shock","volume":"13","author":"Meyer","year":"2009","journal-title":"Crit Care"},{"key":"2026050202262561300_xvag053-B28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"2026050202262561300_xvag053-B29","doi-asserted-by":"publisher","first-page":"F274","DOI":"10.1152\/ajprenal.1989.256.2.F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Physiol"},{"key":"2026050202262561300_xvag053-B30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"2026050202262561300_xvag053-B31","doi-asserted-by":"publisher","first-page":"9920490","DOI":"10.1155\/cdr\/9920490","article-title":"The effect of vasopressin on 90-day mortality in patients with cardiogenic shock: a retrospective cohort study using propensity score-weighted analysis","volume":"2025","author":"Beyls","year":"2025","journal-title":"Cardiovasc Ther"},{"key":"2026050202262561300_xvag053-B32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ahj.2025.03.009","article-title":"Association between vasopressin administration and mortality in patients with cardiogenic shock","volume":"286","author":"Sarma","year":"2025","journal-title":"Am Heart J"},{"key":"2026050202262561300_xvag053-B33","doi-asserted-by":"publisher","first-page":"e020085","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026050202262561300_xvag053-B34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","article-title":"Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the Shock Academic Research Consortium (SHARC)","volume":"148","author":"Waksman","year":"2023","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B35","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehae363","article-title":"Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery","volume":"45","author":"Schlotter","year":"2024","journal-title":"Eur Heart J"},{"key":"2026050202262561300_xvag053-B36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026050202262561300_xvag053-B37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijcard.2022.08.009","article-title":"Sodium nitroprusside in acute heart failure: a multicenter historic cohort study","volume":"369","author":"Garatti","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026050202262561300_xvag053-B38","doi-asserted-by":"publisher","first-page":"e011404","DOI":"10.1161\/CIRCHEARTFAILURE.123.011404","article-title":"Mixed shock complicating cardiogenic shock: frequency, predictors, and clinical outcomes","volume":"17","author":"Baldetti","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026050202262561300_xvag053-B39","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1161\/CIRCULATIONAHA.124.069508","article-title":"Mixed cardiogenic shock: a proposal for standardized classification, a hemodynamic definition, and framework for management","volume":"150","author":"van Diepen","year":"2024","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","article-title":"Sepsis-induced cardiomyopathy: a comprehensive review","volume":"22","author":"L\u2019Heureux","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"2026050202262561300_xvag053-B41","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/eurheartj\/ehaf340","article-title":"Sepsis-induced cardiomyopathy","volume":"46","author":"Aissaoui","year":"2025","journal-title":"Eur Heart J"},{"key":"2026050202262561300_xvag053-B42","doi-asserted-by":"publisher","first-page":"102065","DOI":"10.1016\/j.jaccas.2023.102065","article-title":"Overcoming the obstacle of suicide left ventricle after transcatheter aortic valve replacement phenomenon","volume":"26","author":"Koliastasis","year":"2023","journal-title":"JACC Case Rep"},{"key":"2026050202262561300_xvag053-B43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/jcdd11120401","article-title":"Tailored therapies for cardiogenic shock in hypertrophic cardiomyopathy: navigating emerging strategies","volume":"11","author":"Zakynthinos","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026050202262561300_xvag053-B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41372-020-00824-7","article-title":"Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series","volume":"41","author":"Boyd","year":"2021","journal-title":"J Perinatol"},{"key":"2026050202262561300_xvag053-B45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10557-020-06993-4","article-title":"Vasopressin in patients with septic shock and dynamic left ventricular outflow tract obstruction","volume":"34","author":"Balik","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026050202262561300_xvag053-B46","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B47","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.3390\/jcm10153235","article-title":"Dynamic left intraventricular obstruction phenotype in Takotsubo syndrome","volume":"10","author":"Di Vece","year":"2021","journal-title":"J Clin Med"},{"key":"2026050202262561300_xvag053-B48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/FJC.0000000000001734","article-title":"Treating the broken heart: role of stellate ganglion block in Takotsubo syndrome","volume":"86","author":"Giuliana","year":"2025","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026050202262561300_xvag053-B49","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.jcin.2018.10.046","article-title":"Mechanical circulatory support with Impella percutaneous ventricular assist device as a bridge to recovery in Takotsubo syndrome complicated by cardiogenic shock and left ventricular outflow tract obstruction","volume":"12","author":"Beneduce","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026050202262561300_xvag053-B50","doi-asserted-by":"publisher","first-page":"132681","DOI":"10.1016\/j.ijcard.2024.132681","article-title":"Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: insights from the RETAKO registry","volume":"419","author":"Uribarri","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026050202262561300_xvag053-B51","doi-asserted-by":"publisher","first-page":"102482","DOI":"10.1016\/j.jchf.2025.02.028","article-title":"Vasoplegia syndrome after cardiac surgery: insights into mechanisms and treatment","volume":"13","author":"Castagna","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026050202262561300_xvag053-B52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.33963\/v.phj.99553","article-title":"Usefulness of myocardial damage biomarkers in predicting cardiogenic shock in patients undergoing heart valve surgery","volume":"82","author":"Duchnowski","year":"2024","journal-title":"Kardiol Pol"},{"key":"2026050202262561300_xvag053-B53","doi-asserted-by":"publisher","first-page":"A80","DOI":"10.1016\/j.resuscitation.2020.09.012","article-title":"Adult advanced life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations","volume":"156","author":"Soar","year":"2020","journal-title":"Resuscitation"},{"key":"2026050202262561300_xvag053-B54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.resuscitation.2021.02.010","article-title":"European Resuscitation Council Guidelines 2021: adult advanced life support","volume":"161","author":"Soar","year":"2021","journal-title":"Resuscitation"},{"key":"2026050202262561300_xvag053-B55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.resuscitation.2019.04.008","article-title":"Vasopressors during adult cardiac arrest: a systematic review and meta-analysis","volume":"139","author":"Holmberg","year":"2019","journal-title":"Resuscitation"},{"key":"2026050202262561300_xvag053-B56","doi-asserted-by":"publisher","first-page":"CD003179","DOI":"10.1002\/14651858.CD003179.pub2","article-title":"Adrenaline and vasopressin for cardiac arrest","volume":"1","author":"Finn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026050202262561300_xvag053-B57","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.110.988725","article-title":"Post cardiac arrest syndrome: a review of therapeutic strategies","volume":"123","author":"Stub","year":"2011","journal-title":"Circulation"},{"key":"2026050202262561300_xvag053-B58","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/0885066620918776","article-title":"Structural heart disease emergencies","volume":"36","author":"Jentzer","year":"2021","journal-title":"J Intensive Care Med"},{"key":"2026050202262561300_xvag053-B59","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","article-title":"Effects of norepinephrine on mean systemic pressure and venous return in human septic shock","volume":"40","author":"Persichini","year":"2012","journal-title":"Crit Care Med"},{"key":"2026050202262561300_xvag053-B60","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.3390\/jcm12144722","article-title":"Pressure overload and right ventricular failure: from pathophysiology to treatment","volume":"12","author":"Dayer","year":"2023","journal-title":"J Clin Med"},{"key":"2026050202262561300_xvag053-B61","doi-asserted-by":"publisher","first-page":"e008527","DOI":"10.1161\/CIRCHEARTFAILURE.121.008527","article-title":"Intra-aortic balloon pumping in acute decompensated heart failure with hypoperfusion: from pathophysiology to clinical practice","volume":"14","author":"Baldetti","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026050202262561300_xvag053-B62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.carrev.2020.12.001","article-title":"Vasopressors and inotropes as predictors of mortality in acute severe cardiogenic shock treated with the Impella device","volume":"31","author":"Rohm","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"2026050202262561300_xvag053-B63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"},{"key":"2026050202262561300_xvag053-B64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/SHK.0000000000001747","article-title":"Comparison of vasopressin versus norepinephrine in a pig model of refractory cardiogenic shock complicated by cardiac arrest and resuscitated with veno-arterial ECMO","volume":"56","author":"Klein","year":"2021","journal-title":"Shock"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/advance-article-pdf\/doi\/10.1093\/eschf\/xvag053\/66892787\/xvag053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/1\/xvag053\/66892787\/xvag053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/1\/xvag053\/66892787\/xvag053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:26:34Z","timestamp":1777703194000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/doi\/10.1093\/eschf\/xvag053\/8482915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,13]]},"published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eschf\/xvag053","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"xvag053"}}